|
1
|
Khomich O, Ivanov AV and Bartosch B:
Metabolic hallmarks of hepatic stellate cells in liver fibrosis.
Cells. 9(pii): E242019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang Y, Deng X and Liang J: Modulation of
hepatic stellate cells and reversibility of hepatic fibrosis. Exp
Cell Res. 352:420–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cai X, Wang J, Zhou Q, Yang B, He Q and
Weng Q: Intercellular crosstalk of hepatic stellate cells in liver
fibrosis: New insights into therapy. Pharmacol Res. 155:1047202020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sancho-Bru P and Ginès P: Targeting the
renin-angiotensin system in liver fibrosis. Hepatol Int.
10:730–732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li S, Zhao W, Tao Y and Liu C: Fugan Wan
alleviates hepatic fibrosis by inhibiting ACE/Ang II/AT-1R
signaling pathway and enhancing ACE2/Ang 1-7/Mas signaling pathway
in hepatic fibrosis rat models. Am J Transl Res. 12:592–601.
2020.PubMed/NCBI
|
|
6
|
Bataller R, Ginès P, Nicolás JM, Görbig
MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V and Rodés J:
Angiotensin II induces contraction and proliferation of human
hepatic stellate cells. Gastroenterology. 118:1149–1156. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bataller R, Schwabe RF, Choi YH, Yang L,
Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters
JJ and Brenner DA: NADPH oxidase signal transduces angiotensin II
in hepatic stellate cells and is critical in hepatic fibrosis. J
Clin Invest. 112:1383–1394. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saber S, Goda R, El-Tanbouly GS and Ezzat
D: Lisinopril inhibits nuclear transcription factor kappa B and
augments sensitivity to silymarin in experimental liver fibrosis.
Int Immunopharmacol. 64:340–349. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Czechowska G, Celinski K, Korolczuk A,
Wojcicka G, Dudka J, Bojarska A, Madro A and Brzozowski T: The
effect of the angiotensin II receptor, type 1 receptor antagonists,
losartan and telmisartan, on thioacetamide-induced liver fibrosis
in rats. J Physiol Pharmacol. 67:575–586. 2016.PubMed/NCBI
|
|
10
|
Kim MY, Baik SK, Park DH, Jang YO, Suk KT,
Yea CJ, Lee IY, Kim JW, Kim HS, Kwon SO, et al: Angiotensin
receptor blockers are superior to angiotensin-converting enzyme
inhibitors in the suppression of hepatic fibrosis in a bile
duct-ligated rat model. J Gastroenterol. 43:889–896. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reza HM, Tabassum N, Sagor MA, Chowdhury
MR, Rahman M, Jain P and Alam MA: Angiotensin-converting enzyme
inhibitor prevents oxidative stress, inflammation, and fibrosis in
carbon tetrachloride-treated rat liver. Toxicol Mech Methods.
26:46–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bataller R, Gäbele E, Schoonhoven R,
Morris T, Lehnert M, Yang L, Brenner DA and Rippe RA: Prolonged
infusion of angiotensin II into normal rats induces stellate cell
activation and proinflammatory events in liver. Am J Physiol
Gastrointest Liver Physiol. 285:G642–G651. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Y, Li Y, Lou A, Wang GZ, Hu Y, Zhang
Y, Huang W, Wang J, Li Y, Zhu X, et al: Alamandine attenuates
hepatic fibrosis by regulating autophagy induced by NOX4-dependent
ROS. Clin Sci (Lond). 134:853–869. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei H, Lu H, Li D, Zhan Y, Wang Z and
Huang X: The expression of AT1 receptor on hepatic stellate cells
in rat fibrosis induced by CCl4. Chin Med J (Engl). 114:583–587.
2001.PubMed/NCBI
|
|
15
|
Wang K, Cao P, Wang H, Tang Z, Wang N,
Wang J and Zhang Y: Chronic administration of Angelica
sinensis polysaccharide effectively improves fatty liver and
glucose homeostasis in high-fat diet-fed mice. Sci Rep.
6:262292016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pu X, Fan W, Yu S, Li Y, Ma X, Liu L, Ren
J and Zhang W: Polysaccharides from Angelica and Astragalus exert
hepatoprotective effects against carbon-tetrachloride-induced
intoxication in mice. Can J Physiol Pharmacol. 93:39–43. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee TF, Lin YL and Huang YT: Studies on
antiproliferative effects of phthalides from Ligusticum chuanxiong
in hepatic stellate cells. Planta Med. 73:527–534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Friedman SL, Rockey DC, McGuire RF, Maher
JJ, Boyles JK and Yamasaki G: Isolated hepatic lipocytes and
Kupffer cells from normal human liver: Morphological and functional
characteristics in primary culture. Hepatology. 15:234–243. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sohail MA, Hashmi AZ, Hakim W, Watanabe A,
Zipprich A, Groszmann RJ, Dranoff JA, Torok NJ and Mehal WZ:
Adenosine induces loss of actin stress fibers and inhibits
contraction in hepatic stellate cells via Rho inhibition.
Hepatology. 49:185–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ala-Kokko L, Pihlajaniemi T, Myers JC,
Kivirikko KI and Savolainen ER: Gene expression of type I, III and
IV collagens in hepatic fibrosis induced by dimethylnitrosamine in
the rat. Biochem J. 244:75–79. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li S, Wang Q, Tao Y and Liu C:
Swertiamarin attenuates experimental rat hepatic fibrosis by
suppressing angiotensin II-angiotensin type 1
receptor-extracellular signal-regulated kinase signaling. J
Pharmacol Exp Ther. 359:247–255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei HS, Lu HM, Li DG, Zhan YT, Wang ZR,
Huang X, Cheng JL and Xu QF: The regulatory role of AT 1 receptor
on activated HSCs in hepatic fibrogenesis:Effects of RAS inhibitors
on hepatic fibrosis induced by CCl(4). World J Gastroenterol.
6:824–828. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Y, Li Z, Wang S, Xiu A and Zhang C:
Carvedilol inhibits angiotensin II-induced proliferation and
contraction in hepatic stellate cells through the RhoA/Rho-kinase
pathway. Biomed Res Int. 2019:79320462019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Zhang F, Kong D, Wu X, Lian N,
Chen L, Lu Y and Zheng S: Tetramethylpyrazine inhibits angiotensin
II-induced activation of hepatic stellate cells associated with
interference of platelet-derived growth factor β receptor pathways.
FEBS J. 281:2754–2768. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Meng Y, Wu P, Zhang Z and Yang X:
Angiotensin II and aldosterone stimulating NF-kappaB and AP-1
activation in hepatic fibrosis of rat. Regul Pept. 138:15–25. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang L, Bataller R, Dulyx J, Coffman TM,
Ginès P, Rippe RA and Brenner DA: Attenuated hepatic inflammation
and fibrosis in angiotensin type 1a receptor deficient mice. J
Hepatol. 43:317–323. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang XN, Hu YY, Liu CH, Liu P and Zhu DY:
Effects of salvianolic acid B on expressions of TGF-beta1 and its
receptors in liver of rats with dimethylnitrosamine-induced hepatic
fibrosis. Zhong Xi Yi Jie He Xue Bao. 3:286–289. 2005.(In Chinese).
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ruiz-Ortega M, Lorenzo O, Rupérez M,
Suzuki Y and Egido J: Angiotensin II activates nuclear
transcription factor-kappaB in aorta of normal rats and in vascular
smooth muscle cells of AT1 knockout mice. Nephrol Dial Transplant.
16 (Suppl 1):S27–S33. 2001. View Article : Google Scholar
|
|
29
|
Vogt PK: Jun, the oncoprotein. Oncogene.
20:2365–2377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Donoghue M, Hsieh F, Baronas E, Godbout K,
Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan
R, et al: A novel angiotensin-converting enzyme-related
carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9.
Circ Res. 87:E1–E9. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tipnis SR, Hooper NM, Hyde R, Karran E,
Christie G and Turner AJ: A human homolog of angiotensin-converting
enzyme. Cloning and functional expression as a captopril-
insensitive carboxypeptidase. J Biol Chem. 275:33238–33243. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Santos RA, Ferreira AJ, Verano-Braga T and
Bader M: Angiotensin-converting enzyme 2, angiotensin-(1–7) and
Mas: New players of the renin-angiotensin system. J Endocrinol.
216:R1–R17. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lubel JS, Herath CB, Tchongue J, Grace J,
Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM and
Angus PW: Angiotensin-(1–7), an alternative metabolite of the
renin-angiotensin system, is up-regulated in human liver disease
and has antifibrotic activity in the bile-duct-ligated rat. Clin
Sci (Lond). 117:375–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dasuri K, Zhang L and Keller JN: Oxidative
stress, neurodegeneration, and the balance of protein degradation
and protein synthesis. Free Radic Biol Med. 62:170–185. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Herath CB, Warner FJ, Lubel JS, Dean RG,
Jia Z, Lew RA, Smith AI, Burrell LM and Angus PW: Upregulation of
hepatic angiotensin-converting enzyme 2 (ACE2) and
angiotensin-(1–7) levels in experimental biliary fibrosis. J
Hepatol. 47:387–395. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pereira RM, Dos Santos RA, Teixeira MM,
Leite VH, Costa LP, da Costa Dias FL, Barcelos LS, Collares GB and
Simões e Silva AC: The renin-angiotensin system in a rat model of
hepatic fibrosis: Evidence for a protective role of
Angiotensin-(1-7). J Hepatol. 46:674–681. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Ye Y, Gong H, Wu J, Yuan J, Wang
S, Yin P, Ding Z, Kang L, Jiang Q, et al: The effects of different
angiotensin II type 1 receptor blockers on the regulation of the
ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas axes in pressure
overload-induced cardiac remodeling in male mice. J Mol Cell
Cardiol. 97:180–190. 2016. View Article : Google Scholar : PubMed/NCBI
|
